Publications

Home
Publications

Zerlasiran-A Small-Interfering RNA Targeting Lipoprotein(a): A Phase 2 Randomized Clinical Trial
Published on 2024-11-18 First Author Steven E Nissen
Addressing Knowledge Gaps in Patients With High-Risk Peripheral Artery Disease
Published on 2024-11-11 First Author R Kevin Rogers
Vericiguat Global Study in Participants with Chronic Heart Failure: Design of the VICTOR trial
Published on 2024-10-30 First Author Yogesh N V Reddy
Design and cohort characteristics of TRACK, a prospective study of hyperkalaemia management decision-making
Published on 2024-10-28 First Author Judith Hsia
Duration of Anticoagulation for Venous Thromboembolism in Pediatric Patients: Kids-DOTT Trial Outcomes at Two Years
Published on 2024-10-26 First Author Neil A Goldenberg
Design and Baseline Characteristics of the STRIDE Trial: evaluating Semaglutide in People with Symptomatic Peripheral Artery Disease and Type 2 Diabetes
Published on 2024-10-18 First Author Marc P Bonaca
Is it time to get SIRIUS about in silico modelling of cardiovascular outcomes trials?
Published on 2024-10-08 First Author Marc P Bonaca
Effects of Sotagliflozin on Health Status in Patients With Worsening Heart Failure: Results From SOLOIST-WHF
Published on 2024-09-11 First Author Ankeet S Bhatt
Trends in patient characteristics and mortality among Medicare patients diagnosed with peripheral artery disease
Published on 2024-09-09 First Author Xavier Fowler
Antithrombotic Therapy in Patients Undergoing Peripheral Artery Interventions
Published on 2024-09-08 First Author Mario Enrico Canonico
Triglyceride Levels, Alirocumab Treatment, and Cardiovascular Outcomes After an Acute Coronary Syndrome
Published on 2024-09-04 First Author Doron Zahger
A Novel Urology Preliminary Residency Curriculum Within a Department of Surgery for Unmatched Applicants
Published on 2024-09-02 First Author Tad A Manalo
Antithrombotic Strategies for Patients With Peripheral Artery Disease: JACC Scientific Statement
Published on 2024-08-28 First Author Marc P Bonaca
Low-Dose Rivaroxaban Plus Aspirin in Fragile Patients After Lower Extremity Revascularization
Published on 2024-08-21 First Author Mario Enrico Canonico
Evaluation of an Infrapopliteal Drug-Eluting Resorbable Scaffold: Design Methodology for the LIFE-BTK Randomized Controlled Trial
Published on 2024-08-12 First Author Ramon L Varcoe
Clonal hematopoiesis, cardiovascular events and treatment benefit in 63,700 individuals from five TIMI randomized trials
Published on 2024-08-06 First Author Nicholas A Marston
Demystifying the Contemporary Role of 12-Month Dual Antiplatelet Therapy After Acute Coronary Syndrome
Published on 2024-07-22 First Author Marco Valgimigli
Epidemiology and Burden of Peripheral Artery Disease in People With Type 2 Diabetes: A Systematic Literature Review
Published on 2024-07-18 First Author Subodh Verma
Efficacy and safety of SGLT2 inhibitors with and without glucagon-like peptide 1 receptor agonists: a SMART-C collaborative meta-analysis of randomised controlled trials
Published on 2024-07-11 First Author Ellen M Apperloo
Rivaroxaban Versus Apixaban: A Comparison Without a Simple Solution
Published on 2024-07-08 First Author Marc Cohen
Alirocumab and cardiovascular outcomes according to sex and lipoprotein(a) after acute coronary syndrome: a report from the ODYSSEY OUTCOMES study
Published on 2024-07-03 First Author Vera A Bittner
Results of the Phase 1 Open-Label Safety Study of Umbilical Cord Lining Mesenchymal Stromal/Stem Cells (Corlicyte®) to Heal Chronic Diabetic Foot Ulcers
Published on 2024-06-27 First Author Cecilia C Low Wang
Migraine headache in patients with spontaneous coronary artery dissection: A report of the iSCAD Registry
Published on 2024-06-20 First Author Bryan J Wells
Randomized Trial of a Vascular Care Team vs Education for Patients With Peripheral Artery Disease
Published on 2024-06-19 First Author Connie N Hess
Association between tissue loss type and amputation risk among Medicare patients with concomitant diabetes and peripheral arterial disease
Published on 2024-06-16 First Author Aravind S Ponukumati
Co-Morbidity Differences Associated With Long-Term Amputation and Repeat Revascularization Rates After Femoropopliteal Artery Intervention for Intermittent Claudication by Sex, Race, and Ethnicity
Published on 2024-06-04 First Author S Elissa Altin
2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Published on 2024-05-16 First Author Writing Committee Members
Stepping Into the Future of Care for Patients With Peripheral Artery Disease
Published on 2024-05-14 First Author Marc P Bonaca
2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Published on 2024-05-14 First Author Heather L Gornik
Polyvascular Disease: A Narrative Review of Risk Factors, Clinical Outcomes and Treatment
Published on 2024-05-14 First Author Manasi Tannu
Low-Dose Rivaroxaban Plus Aspirin in Patients With Peripheral Artery Disease Undergoing Lower Extremity Revascularization With and Without Concomitant Coronary Artery Disease: Insights From VOYAGER PAD
Published on 2024-05-06 First Author Justin T Morrison
Medical Therapy for Peripheral Artery Disease
Published on 2024-05-02 First Author Mario Enrico Canonico
Low absolute risk of thrombotic and cardiovascular events in outpatient pregnant women with COVID-19
Published on 2024-04-27 First Author Behnood Bikdeli
Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation
Published on 2024-04-24 First Author Shaun G Goodman
Limb Outcomes With Ticagrelor Plus Aspirin in Patients With Diabetes Mellitus and Atherosclerosis
Published on 2024-04-24 First Author Marc P Bonaca
Continuous Glucose Monitoring for Prediabetes: What Are the Best Metrics?
Published on 2024-04-17 First Author Salwa J Zahalka
Time to clinical benefit with sotagliflozin in patients with type 2 diabetes and chronic kidney disease: Insights from the SCORED randomized trial
Published on 2024-04-17 First Author Rahul Aggarwal
Atherosclerosis evaluation and cardiovascular risk estimation using coronary computed tomography angiography
Published on 2024-04-12 First Author Nick S Nurmohamed
Quantitative Benefit-Risk Evaluation of Rivaroxaban in Patients After Peripheral Arterial Revascularization: The VOYAGER PAD Trial
Published on 2024-04-02 First Author Zhong Yuan
Posttraumatic Stress Disorder After Spontaneous Coronary Artery Dissection: A Report of the International Spontaneous Coronary Artery Dissection Registry
Published on 2024-03-27 First Author Jennifer A Sumner
Lipoprotein(a) Blood Levels and Cardiovascular Risk Reduction With Icosapent Ethyl
Published on 2024-03-26 First Author Michael Szarek
The "Woundosome" Concept and Its Impact on Procedural Outcomes in Patients With Chronic Limb-Threatening Ischemia
Published on 2024-03-25 First Author Lorenzo Patrone
Comparison of change in lipoprotein(a) mass and molar concentrations by alirocumab and risk of subsequent cardiovascular events in ODYSSEY OUTCOMES
Published on 2024-03-19 First Author Michael Szarek
Methods, design, and initial results of an angiographic core lab from VOYAGER-PAD
Published on 2024-03-17 First Author R Kevin Rogers
Novel Polygenic Risk Score and Established Clinical Risk Factors for Risk Estimation of Aortic Stenosis
Published on 2024-02-28 First Author Aeron M Small
Current Gaps in the Provision of Safe and Effective Anticoagulation in Atrial Fibrillation and the Potential for Factor XI-Directed Therapeutics
Published on 2024-02-21 First Author Shaun G Goodman
Unplanned Index Limb Revascularization With Rivaroxaban Versus Placebo in Patients With Critical Limb-Threatening Ischemia After Endovascular and Surgical Treatment: Insights From VOYAGER PAD
Published on 2024-02-20 First Author Shea E Hogan
Bleeding Outcomes in Patients Treated With Asundexian in Phase II Trials
Published on 2024-02-07 First Author John W Eikelboom
Safety and Efficacy of Insulins in Critically Ill Patients Receiving Continuous Enteral Nutrition
Published on 2024-02-02 First Author Kevin Ni
BEST-CLI International Collaborative: planning a better future for patients with chronic limb-threatening ischaemia globally
Published on 2024-01-31 First Author Alik Farber
Sotagliflozin and Kidney Outcomes, Kidney Function, and Albuminuria in Type 2 Diabetes and CKD: A Secondary Analysis of the SCORED Trial
Published on 2024-01-26 First Author Vikas S Sridhar
Rosiglitazone improves insulin resistance but does not improve exercise capacity in individuals with impaired glucose tolerance: A randomized clinical study
Published on 2023-12-26 First Author Layla A Abushamat
Recapturing the Team Approach to Vascular Care
Published on 2023-12-21 First Author Herbert D Aronow
Lipoprotein(a) and Benefit of Antiplatelet Therapy: Insights from the PEGASUS-TIMI 54 Trial
Published on 2023-12-18 First Author Siddharth M Patel
Antithrombotic Prophylaxis with Rivaroxaban in Patients with Prehospital COVID-19: A Meta-analysis of Two Placebo-Controlled Trials
Published on 2023-11-23 First Author Judith Hsia
A methodology of phenotyping ICU patients from EHR data: High-fidelity, personalized, and interpretable phenotypes estimation
Published on 2023-11-20 First Author Yanran Wang
Pharmacologic and Genetic Downregulation of Proprotein Convertase Subtilisin/Kexin Type 9 and Survival From Sepsis
Published on 2023-11-13 First Author Patrick R Lawler
Efficacy of Sotagliflozin in Adults With Type 2 Diabetes in Relation to Baseline Hemoglobin A1c
Published on 2023-11-01 First Author Rahul Aggarwal
Drug-Eluting Resorbable Scaffold versus Angioplasty for Infrapopliteal Artery Disease
Published on 2023-10-27 First Author Ramon L Varcoe
Rivaroxaban Plus Aspirin Versus Aspirin Alone After Endovascular Revascularization for Symptomatic PAD: Insights From VOYAGER PAD
Published on 2023-10-18 First Author Jennifer Rymer
Long-Term Efficacy, Safety, and Tolerability of Alirocumab in 8242 Patients Eligible for 3 to 5 Years of Placebo-Controlled Observation in the ODYSSEY OUTCOMES Trial
Published on 2023-09-13 First Author Shaun G Goodman
Advances in the management of type 2 diabetes in adults
Published on 2023-09-08 First Author Rodolfo J Galindo
Left Ventricular Ejection Fraction in Patients With Ovarian Cancer Treated With Avelumab, Pegylated Liposomal Doxorubicin, or Both
Published on 2023-09-04 First Author Marc P Bonaca
A methodology of phenotyping ICU patients from EHR data: high-fidelity, personalized, and interpretable phenotypes estimation
Published on 2023-09-04 First Author Yanran Wang
Initiating Mineralocorticoid Antagonists for Longstanding Heart Failure With Reduced Ejection Fraction: Better Late Than Never?
Published on 2023-08-29 First Author Andrew J Sauer
Relating Lipoprotein(a) Concentrations to Cardiovascular Event Risk After Acute Coronary Syndrome: A Comparison of 3 Tests
Published on 2023-08-26 First Author Michael Szarek
Women, lipids, and atherosclerotic cardiovascular disease: a call to action from the European Atherosclerosis Society
Published on 2023-08-23 First Author Jeanine E Roeters van Lennep
Effect of Sotagliflozin on Early Mortality and Heart Failure-Related Events: A Post Hoc Analysis of SOLOIST-WHF
Published on 2023-08-09 First Author Bertram Pitt
2023 AHA/ACC Clinical Performance and Quality Measures for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Performance Measures
Published on 2023-07-30 First Author Writing Committee Members
2023 AHA/ACC Clinical Performance and Quality Measures for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Performance Measures
Published on 2023-07-27 First Author Gregory J Dehmer
A simple modeling framework for prediction in the human glucose-insulin system
Published on 2023-07-24 First Author Melike Sirlanci
Effect of proprotein convertase subtilisin/kexin type 9 inhibition on cancer events: A pooled, post hoc, competing risk analysis of alirocumab clinical trials
Published on 2023-07-17 First Author Kusha A Mohammadi
Long-Term Patient Outcomes After Femoropopliteal Peripheral Vascular Intervention in Patients With Intermittent Claudication
Published on 2023-07-12 First Author S Elissa Altin
Effect of sotagliflozin on albuminuria in patients with type 2 diabetes and chronic kidney disease
Published on 2023-07-10 First Author David Z I Cherney
Correction: Effect of alirocumab on cataracts in patients with acute coronary syndromes
Published on 2023-07-06 First Author Gaspard Suc
Novel Tissue Factor Inhibition for Thromboprophylaxis in COVID-19: Primary Results of the ASPEN-COVID-19 Trial
Published on 2023-06-29 First Author Connie N Hess
Trends of Concomitant Diabetes and Peripheral Artery Disease and Lower Extremity Amputation in US Medicare Patients, 2007 to 2019
Published on 2023-06-20 First Author Xavier P Fowler
Effect of alirocumab on cataracts in patients with acute coronary syndromes
Published on 2023-06-16 First Author Gaspard Suc
Major cardiovascular events after COVID-19, event rates post-vaccination, antiviral or anti-inflammatory therapy, and temporal trends: Rationale and methodology of the CORONA-VTE-Network study
Published on 2023-06-11 First Author Behnood Bikdeli
Effects of Elective Coronary Revascularization vs Medical Therapy Alone on Noncardiac Mortality: A Meta-Analysis
Published on 2023-05-24 First Author Eliano P Navarese
In-Hospital Use of PCSK9 Inhibitors in the Post ACS Patient: What Does the Evidence Show?
Published on 2023-05-24 First Author Mario Enrico Canonico
Presence of Peripheral Artery Disease Is Associated With Increased Risk of Heart Failure Events: Insights From EMPEROR-Pooled
Published on 2023-05-18 First Author Subodh Verma
Digital Health and Shared Decision-Making in Diabetes Care - A Survey Initiative in Patients and Clinicians
Published on 2023-05-13 First Author Faiza Mubeen
Treatment of Cancer-Associated Thrombosis: Recent Advances, Unmet Needs, and Future Direction
Published on 2023-05-12 First Author Tzu-Fei Wang
Rivaroxaban for Prevention of Thrombotic Events, Hospitalization, and Death in Outpatients With COVID-19: A Randomized Clinical Trial
Published on 2023-05-08 First Author Gregory Piazza
American Association of Clinical Endocrinology Consensus Statement: Comprehensive Type 2 Diabetes Management Algorithm - 2023 Update
Published on 2023-05-07 First Author Susan L Samson
Lipoprotein(a) and the Effect of Alirocumab on Revascularization After Acute Coronary Syndrome
Published on 2023-04-28 First Author P Gabriel Steg
Antithrombotic Therapy in Peripheral Artery Disease: Current Evidence and Future Directions
Published on 2023-04-27 First Author Mario Enrico Canonico
Impaired angiogenesis in diabetic critical limb ischemia is mediated by a miR-130b/INHBA signaling axis
Published on 2023-04-25 First Author Henry S Cheng
Time to Benefit With Sotagliflozin in Patients With Worsening Heart Failure
Published on 2023-04-12 First Author Subodh Verma
Transiently achieved very low LDL-cholesterol levels by statin and alirocumab after acute coronary syndrome are associated with cardiovascular risk reduction: the ODYSSEY OUTCOMES trial
Published on 2023-03-07 First Author Gregory G Schwartz
Sex differences in guideline-directed medical therapy in 2021-22 among patients with peripheral artery disease
Published on 2023-02-27 First Author Mario Enrico Canonico
A miRNA/CXCR4 signaling axis impairs monopoiesis and angiogenesis in diabetic critical limb ischemia
Published on 2023-02-23 First Author Henry S Cheng
Guideline-Directed Medical Therapy in PAD: Time to Step on the Gas
Published on 2023-02-15 First Author Connie N Hess
Influence of body weight and body mass index on the chronic pharmacokinetic and pharmacodynamic responses to clinically available doses of ticagrelor in patients with chronic coronary syndromes
Published on 2023-01-31 First Author William A E Parker
Tradeoffs in Approach to PAD Revascularization: Shared Decision Making in the Spotlight
Published on 2023-01-25 First Author Marc P Bonaca
Response to Mei et al. regarding the incidence and predictors of hospitalization for heart failure among patients with stable atherosclerosis in the TRA 2°P-TIMI 50 trial
Published on 2023-01-24 First Author Benjamin L Freedman
Burden of Cardiovascular Disease in Immune Checkpoint Inhibitor-Treated Patients: Reconciling Adjudicated and Coded Outcomes
Published on 2023-01-13 First Author Lavanya Kondapalli
What Is the Evidence of the Diagnostic Criteria and Screening of Immune Checkpoint Inhibitor-Induced Myocarditis?
Published on 2023-01-13 First Author Franck Thuny
ACC/AHA Aortic Disease Guidelines: What Was Simple Is Now Complex-Moving to Multidisciplinary Teams, Specialized Centers
Published on 2022-12-08 First Author Marc P Bonaca